ABSTRACT This early-stage company is a pioneer in genetic testing targeted at early diagnosis of autism in children. The technology is new, and its benefits were not well understood by insurance providers. The company relied on an outsource billing company for reimbursements, but found that claims were outstanding for over one year, and the third-party billing relationship insulated them from crucial in-depth discussions with insurance com

Join for free to read